Showing results (231-240 of 264) with videos related to

Sort By:
Pageof 27
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 1, 1996
The prognostic impact of the urokinase-type plasminogen activator system is associated with tumour differentiation in gastric cancerM M Heiss, R Babic, H Allgayer, et al.
Advances in Medical Sciences|January 15, 2013
Differences in the treatment of young gastric cancer patients: patients under 50 years have better 5-year survival than older patientsC W Schildberg, R Croner, V Schellerer, et al.
Clinical & Experimental Metastasis|March 21, 1998
Tumor-associated proteases and inhibitors in gastric cancer: analysis of prognostic impact and individual risk protease patternsH Allgayer, R Babic, K U Grützner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1995
Tumor-associated proteolysis and prognosis: new functional risk factors in gastric cancer defined by the urokinase-type plasminogen activator systemM M Heiss, R Babic, H Allgayer, et al.
Lancet (London, England)|October 23, 1993
De-novo expression of CD44 and survival in gastric cancerB Mayer, K W Jauch, U Günthert, et al.
Oncology|March 14, 1998
Prognostic relevance of MMP-2 (72-kD collagenase IV) in gastric cancerH Allgayer, R Babic, B C Beyer, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|June 5, 2003
Efficacy and tolerance of a new gentamicin collagen fleece (Septocoll) after surgical treatment of a pilonidal sinusB Holzer, U Grüssner, B Brückner, et al.
Pageof 27